Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma—A 3-D In Vitro Study

Malignant peritoneal mesothelioma is a rare tumor entity. Although cytoreductive surgery and hyperthermic intraperitoneal chemotherapy have increased overall survival, its prognosis remains poor. Established chemotherapeutics include mitomycin C (MMC) and cisplatin (CP), both characterized by severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Claudia, Buchholz, Marie, Majchrzak-Stiller, Britta, Peters, Ilka, Fein, Daniel, Müller, Thomas, Uhl, Waldemar, Höhn, Philipp, Strotmann, Johanna, Braumann, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267014/
https://www.ncbi.nlm.nih.gov/pubmed/35806313
http://dx.doi.org/10.3390/ijms23137293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267014/
https://www.ncbi.nlm.nih.gov/pubmed/35806313
http://dx.doi.org/10.3390/ijms23137293

Ejemplares similares